Xencor, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 16/10/2026 BST			5-day change	1st Jan Change
22.85 ^USD	-4.79%		-7.23%	+49.25%

09-25	Xencor's XmAb819 Data Could Support Registrational Path, Wedbush Says	MT
09-21	BofA Adjusts Price Target on Xencor to $26 From $20, Keeps Neutral Rating	MT

Published on 05/05/2026 at 08:20 pm BST - Modified on 06/19/2026 at 06:51 am BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, and welcome to the Xencor DDW 2026 Webcast. [Operator Instructions] Also, reminder, this conference is being recorded today. If you have any

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

09-25	Xencor's XmAb819 Data Could Support Registrational Path, Wedbush Says	MT
09-21	BofA Adjusts Price Target on Xencor to $26 From $20, Keeps Neutral Rating	MT
09-01	Raymond James Adjusts Xencor Price Target to $46 From $40, Maintains Strong Buy Rating	MT
08-06	Wedbush Adjusts Price Target on Xencor to $30 From $26, Maintains Outperform Rating	MT
08-06	RBC Capital Adjusts PT on Xencor to $20 From $19, Maintains Outperform Speculative Risk Rating	MT
08-05	Earnings Flash (XNCR) Xencor, Inc. Reports Q2 Revenue $51.2M, vs. FactSet Est of $18.9M	MT
08-05	Xencor, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-30	Xencor Shares Rise After Settlement Deal With Alexion	MT
07-17	Xencor's Cancer Drug Study Selected for Oral Presentation at ESMO; Shares Rise	MT
05-13	Xencor, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:00 PM
05-06	Earnings Flash (XNCR) Xencor, Inc. Reports Q1 Revenue $4.5M	MT
05-06	Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Xencor, Inc. - Special Call
05-04	Xencor Inc Reports Final Results Of Phase 1 Study Of XmAb942 And Provides Update On XmAb412	CI
03-24	Xencor Shares Fall After JPMorgan Downgrade	MT

Duration

Period

Sector